Latest filings (excl ownership)
424B3
Prospectus supplement
13 Dec 10
EFFECT
Notice of effectiveness
10 Dec 10
UPLOAD
Letter from SEC
30 Nov 10
D
$400M in debt / Subsidiary Guarantees, sold $400M, 5 investors
6 Oct 10
8-K
Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2016
25 May 10
424B3
Prospectus supplement
23 Apr 10
EFFECT
Notice of effectiveness
21 Apr 10
POSASR
Automatic shelf registration (post-effective amendment)
29 Mar 10
D
$100M in debt / Subsidiary Guarantees, sold $100M, 3 investors
13 Oct 09
424B5
Prospectus supplement for primary offering
6 Aug 09
424B5
Prospectus supplement for primary offering
4 Aug 09
POSASR
Automatic shelf registration (post-effective amendment)
4 Aug 09
8-A12B
Registration of securities on exchange
12 May 09
424B5
Prospectus supplement for primary offering
8 May 09
424B5
Prospectus supplement for primary offering
4 May 09
S-3ASR
Automatic shelf registration
10 Apr 09
424B3
Prospectus supplement
16 Feb 05
POS AM
Prospectus update (post-effective amendment)
27 Oct 03
RW
Registration withdrawal request
24 Oct 03
S-3/A
Shelf registration (amended)
10 Jan 03
S-3
Shelf registration
20 Dec 02
POS AM
Prospectus update (post-effective amendment)
14 Jun 02
S-3/A
Shelf registration (amended)
20 Feb 02
S-3/A
Shelf registration (amended)
22 Jan 02
S-3
Shelf registration
21 Dec 01
S-4
Registration of securities issued in business combination transactions
1 Jun 01
Latest ownership filings
No filings